{"a":[{"_":"Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech","$":{"href":"/biotech/lilly-pledges-237m-program-cns-genetic-med-collab-canadian-biotech","hreflang":"en"}}]}

Summary

Eli Lilly announced a collaboration with Canadian biotech QurCan Therapeutics for CNS genetic medicine development, pledging up to $237 million in biobucks per program to strengthen its genetic medicine portfolio.